{"id":"NCT05498467","sponsor":"Herlev and Gentofte Hospital","briefTitle":"The Role of Interleukin-1 Beta Targeted Therapy for Patients Suffering From Allergic Contact Dermatitis","officialTitle":"The Role of Interleukin-1 Beta Targeted Therapy for Patients Suffering From Allergic Contact Dermatitis: A Randomized Controlled Trial With Anakinra vs. Placebo","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2022-10-11","primaryCompletion":"2023-12-01","completion":"2024-08-01","firstPosted":"2022-08-12","resultsPosted":"2025-05-20","lastUpdate":"2025-05-20"},"enrollment":20,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Allergic Contact Dermatitis"],"interventions":[{"type":"DRUG","name":"Anakinra","otherNames":[]},{"type":"DRUG","name":"Sodium Chloride 9mg/ml Injection","otherNames":[]}],"arms":[{"label":"Anakinra","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The study will investigate if Anakinra can ameliorate allergic contact dermatitis in participants with known nickel allergy","primaryOutcome":{"measure":"Clinical Reaction","timeFrame":"2 months","effectByArm":[{"arm":"Anakinra","deltaMin":0,"sd":null},{"arm":"Placebo","deltaMin":0,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":6,"exclusionCount":10},"locations":{"siteCount":1,"countries":["Denmark"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":12},"commonTop":[]}}